The parliament of Lithuania has passed a law that will make it possible for patients who want to be treated with marijuana to get such treatment. This new law will become operational on May 1, 2019. An overwhelming majority (nearly unanimous) of legislators voted in for this law. No legislator voted against the proposal while one lawmaker abstained.
Any company intending to sell medical cannabis once the new law takes effect will need to get a license from the relevant regulator in the country.
The passing of the law which legalized medical cannabis necessitated that some existing laws, such as the law on Narcotics and Psychotropic Substances, be amended to take into account the legalization of medical marijuana.
One of the provisions of the narcotics law regarded marijuana as having no medicinal use. Such a provision would have been inconsistent with the new law which regarded cannabis as a form of medicine.
The law legalizing medical cannabis has some strict requirements for any cannabis product that manufacturers want to use to treat patients. For example, scientific research will have to be conducted to prove that a given product has a medicinal effect upon the condition for which such a product can be used.
The medicines control agency of the country will be responsible for issuing permits for any clinical trials that need to be conducted.
Aurora Cannabis, one of the leading marijuana companies in Canada, already has a presence in the country. This was after the Canadian company acquired Agropro UAB in September this year.
Agropro had for long occupied the position of the largest firm involved in the production, processing and supply of organic hemp products in Europe.
Registered cannabis products will be used to treat oncological patients in Lithuania. Qualifying conditions will include HIV/AIDS, multiple sclerosis, severe epilepsy and other chronic conditions.
Other EU jurisdictions which have recently legalized medical cannabis include the UK which passed the relevant law and implementation is scheduled to start just weeks after that law was passed. This is contrary to what happens in other jurisdictions where several months or even years have to elapse before implementation starts. The delays are usually necessitated by the need to set up regulatory systems and process applications for businesses that want to be involved in the industry.
Lithuania is taking it slow and giving itself more than half a year before patients can access medical marijuana. Cannabis companies around the world, such as Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) are certainly happy that more jurisdictions around the world are opening up to the medical benefits that cannabis can offer those in need.
More from CannabisNewsWire
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
